Advocates for the full publication of all clinical trials on endothelin antagonists in heart failure to better understand their lack of benefit.
The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.
No takes yet. Share an insight, caveat, or question.
Kelland et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: